Katherine Strei - 23 Feb 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief HR Officer
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2022
Net transactions value
-$39,584
Form type
4
Filing time
25 Feb 2022, 16:19:34 UTC
Previous filing
24 Feb 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $14,527 -344 -1.1% $42.23 30,798 23 Feb 2022 Direct F1
transaction EBS Common Stock Tax liability $25,057 -590 -1.9% $42.47 30,208 24 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.